查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1804633

栓剂市场按产品类型、材料类型、配方类型、治疗用途、最终用户和分销管道划分 - 2025-2030 年全球预测

Suppositories Market by Product Type, Material Type, Prescription Type, Therapeutic Application, End User, Distribution Channel - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 196 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

预计 2024 年栓剂市场价值将达到 15.4 亿美元，2025 年将成长至 16.3 亿美元，到 2030 年将达到 21.8 亿美元，复合年增长率为 5.95%。

主要市场统计数据
基准年2024年 15.4亿美元
预计2025年 16.3亿美元
预测年份 2030 21.8亿美元
复合年增长率（%） 5.95%

探索栓剂疗法在现代医疗保健中针对不同患者需求和临床情况不断演变的作用

栓剂疗法的演变是现代医疗保健中一个重要但常常被低估的面向。数十年来，栓剂疗法已从最初的简陋配方发展成为成熟的给药载体，能够有效提升患者舒适度、改善药物动力学并增强疗效。随着临床医生和医疗保健专业人员寻求更可靠的口服给药替代方案（无论是为了避免胃肠不适还是为了快速缓解局部症状），栓剂已成为从疼痛管理到痔疮治疗等众多领域的重要干预手段。

监管审查和以患者为中心的趋势塑造了全球栓剂的未来，并确定了关键创新

在技​​术突破、监管格局调整以及患者期望不断变化等因素的推动下，栓剂行业正在经历一场变革。材料科学的进步促成了新型基质成分的引入，从促进药物快速释放的乳化基质，到改善物料输送品管等改进的製造工艺，确保了批次间的一致性，并降低了治疗结果的差异性。

2025年美国新关税对原料供应链和产业竞争的广泛影响分析

2025年，美国对关键医药成分征收更高的关税，为依赖进口辅料的栓剂製造商带来了巨大的阻力。从聚乙二醇衍生物到甘油明胶基质，关税上调增加了投入成本，并导致价格结构波动。企业现在面临着如何在维持产品品质和竞争优势的同时，应对不断变化的关税分类的挑战。

对产品变化、材料成分、配方动态、治疗应用、最终用户偏好和分销趋势有深入的了解

依产品类型细分，可以发现直肠栓、尿道栓和阴道栓剂的不同性能驱动因素和临床考虑。直肠栓剂因其吸收更快、给药方便，在镇痛和止吐应用中仍占据主导地位；而尿道栓剂则满足特殊的泌尿系统需求，并受益于聚合物相容性的进步。同时，由于患者偏好隐藏的局部治疗，阴道栓剂在抗菌、抗真菌和抗痔疮治疗中也越来越受欢迎。

检验美洲、欧洲和亚太地区对栓剂生产和分销的监管和患者需求的差异

在美洲，美国、加拿大和巴西等主要市场的监管协调为栓剂创新创造了良好的环境。患者对肠外治疗的需求仍然旺盛，尤其是在慢性疼痛管理和直肠病学领域，鼓励当地企业投资先进的平台技术并拓展临床试验计画。同时，连接南北美洲的贸易走廊促进了原材料的交换，而近期的关税措施也促使相关人员在该地区探索新的采购合作伙伴关係。

介绍促进创新合作和策略伙伴关係以推动栓剂开发和市场发展的主要企业

领先的製药和製剂公司正透过对研究伙伴关係和垂直整合的策略性投资来推进栓剂科学的发展。领先的创新者正与辅料专家合作，共同开发可增强药物负载和控制释放的下一代载体。这些合作以共用实验室平台和联合智慧财产权申请为支撑，使合作伙伴能够加速产品平臺，并缩短临床检验时间。

制定策略建议，指导产业领导层优化供应链；加强合作，抓住新的栓剂机会

产业领导者应优先考虑供应链的弹性，透过多元化筹资策略并与区域辅料供应商建立伙伴关係，从而减轻关税和不断变化的合规环境的影响。投资先进的平台技术，例如生物分解性的聚合物和响应生理触发的智慧辅料，可以释放新的治疗潜力，并在竞争激烈的市场中实现配方的差异化。

详细介绍了一种严谨的研究途径，该方法结合了主要专家的参与、二手文献分析和定量数据综合，以获得可靠的见解

本研究报告基于多层次的调查方法，旨在提供可靠且可操作的洞察。主要研究包括对製剂科学家、法规专家、供应链经理和患者权益代表的深入访谈，以收集新兴趋势和业务挑战的第一手观点。这些定性资讯与来自同行评审期刊、行业白皮书、监管文件和技术会议论文集的二次研究结果相结合。

整合关键发现和策略意义，阐明栓剂在医疗实务中的创新与应用前景

本报告透过对变革性创新、关税主导的供应链重组以及细緻入微的细分市场动态的分析，揭示了快速演变的栓剂产业格局。随着材料科学的突破性进展、以永续性为重点的法规以及数位健康的融合，栓剂产业有望对医疗保健产生重大影响。

目录

第一章：前言

第二章调查方法

第三章执行摘要

第四章 市场概述

第五章市场动态

  • 热带市场越来越多地采用温度稳定的脂质栓剂
  • 开发增强药物控制释放特性的黏膜附着性聚合物製剂
  • 小儿科和老年医学对客製化剂量解决方案的需求不断增长
  • 整合数位健康监测以优化患者依从性和治疗结果
  • 人们对植物来源和天然赋形剂型栓剂的偏好日益增加
  • 3D 列印技术的进步使个人化栓剂输送和快速原型製作成为可能
  • 监管变化正在简化新型直肠给药系统的核准
  • 由于新兴国家医疗保健服务水准的提高，栓剂市场不断扩大

第六章 市场洞察

  • 波特五力分析
  • PESTEL分析

第七章 2025年美国关税的累积影响

第 8 章栓剂市场（依产品类型）

  • 直肠栓剂
  • 尿道栓剂
  • 阴道栓剂

9. 栓剂市场（依材料类型）

  • 乳化基质
  • 脂肪基质
  • 甘油明胶基质
  • 聚乙二醇基
    • PEG 3350
    • PEG 4000
  • 水溶性碱

第 10 章栓剂市场（按剂型）

  • 非处方药
  • 处方药（Rx）

第 11 章栓剂市场（依治疗用途）

  • 止痛药
    • 对乙酰胺酚止痛药
    • 非类固醇抗发炎药止痛药
  • 消炎（药）
  • 抗菌/抗真菌
  • 止吐药
  • 痔疮治疗药物
    • 非类固醇类药物
    • 类固醇製剂
  • 泻药

第 12 章栓剂市场（依最终用户划分）

  • 居家照护
  • 医院和诊所

第十三章栓剂市场（依通路）

  • 线下药局
  • 网路药局

第 14 章：美洲栓剂市场

  • 美国
  • 加拿大
  • 墨西哥
  • 巴西
  • 阿根廷

15.欧洲、中东和非洲栓剂市场

  • 英国
  • 德国
  • 法国
  • 俄罗斯
  • 义大利
  • 西班牙
  • 阿拉伯聯合大公国
  • 沙乌地阿拉伯
  • 南非
  • 丹麦
  • 荷兰
  • 卡达
  • 芬兰
  • 瑞典
  • 奈及利亚
  • 埃及
  • 土耳其
  • 以色列
  • 挪威
  • 波兰
  • 瑞士

16.亚太栓剂市场

  • 中国
  • 印度
  • 日本
  • 澳洲
  • 韩国
  • 印尼
  • 泰国
  • 菲律宾
  • 马来西亚
  • 新加坡
  • 越南
  • 台湾

第十七章竞争格局

  • 2024年市场占有率分析
  • 2024年FPNV定位矩阵
  • 竞争分析
    • Novartis AG
    • SANOFI WINTHROP INDUSTRIE
    • Zydus Group
    • Church & Dwight Co., Inc.
    • Bausch Health Companies Inc.
    • Teva Pharmaceutical Industries Ltd.
    • Sun Pharmaceutical Industries Ltd.
    • Aspen Holdings
    • Haleon Group of Companies
    • Cipla Limited
    • Gulf Pharmaceutical Industries
    • Prestige Consumer Healthcare Inc.
    • Bliss GVS Pharma Ltd
    • Corden Pharma
    • Recipharm AB
    • Pfizer Inc.
    • LGM Pharma, LLC
    • Aenova Group
    • Bayer AG
    • Aliyan Pharmaceuticals LLP
    • Adragos Pharma GmbH

第十八章 研究人工智慧

第十九章 研究统计

第二十章 研究联络人

第21章 研究报导

第22章 附录

Product Code: MRR-0B6B418766D4

The Suppositories Market was valued at USD 1.54 billion in 2024 and is projected to grow to USD 1.63 billion in 2025, with a CAGR of 5.95%, reaching USD 2.18 billion by 2030.

KEY MARKET STATISTICS
Base Year [2024] USD 1.54 billion
Estimated Year [2025] USD 1.63 billion
Forecast Year [2030] USD 2.18 billion
CAGR (%) 5.95%

Discovering the Evolutionary Role of Suppository Therapies in Modern Healthcare Across Diverse Patient Needs and Clinical Scenarios

The evolution of suppository therapies has been a critical yet often under-appreciated facet of modern healthcare. Over the decades, the modality has matured from rudimentary formulations into sophisticated delivery vehicles that address patient comfort, pharmacokinetics, and targeted efficacy. As clinicians and caregivers seek more reliable alternatives to oral administration-whether to bypass gastrointestinal degradation or to provide rapid local relief-suppositories have emerged as a vital intervention in fields ranging from pain management to antihemorrhoidal treatment.

Transitioning from simple fatty bases to advanced water-soluble and polyethylene glycol platforms, manufacturers have prioritized consistency, shelf stability, and patient acceptability. These iterative improvements reflect broader shifts in pharmaceutical science, where precision engineering of excipients and active ingredients can enhance bioavailability and reduce adverse effects. Concurrently, the rise of personalized medicine has ignited renewed interest in dosage form customization, encouraging research into novel emulsifying systems and hybrid polymer matrices that can be tailored to individual metabolic profiles.

Beyond formulation advances, widespread patient education and evolving reimbursement frameworks have converged to elevate suppositories as a mainstream therapeutic option. From home care settings to hospitals and clinics, this dosage form now bridges critical gaps in chronic and acute care pathways. Recognizing this multifaceted progression sets the stage for deeper analysis of transformative trends, regulatory influences, and competitive dynamics that will define the next chapter in suppository innovation.

Identifying Pivotal Technological Innovations Regulatory Overhauls and Patient-Centric Trends Reshaping the Future of Suppository Drug Delivery Worldwide

The suppository landscape is experiencing a wave of transformative shifts driven by technological breakthroughs, regulatory recalibrations, and evolving patient expectations. Advances in materials science have enabled the introduction of new base compositions-ranging from emulsifying bases that facilitate rapid drug release to water-soluble bases that improve handling and patient comfort. These material innovations dovetail with enhanced manufacturing processes, including precision molding and automated quality controls, that ensure consistency across batches and reduce variability in therapeutic outcomes.

Meanwhile, regulatory authorities worldwide are tightening guidelines around excipient safety and environmental impact. Initiatives aimed at reducing residual solvents, minimizing plastic packaging waste, and ensuring full traceability within supply chains are prompting manufacturers to reassess sourcing strategies and invest in greener technologies. As a result, compliance has become a competitive differentiator, with early adopters of next-generation excipient screening and sustainable packaging gaining recognition for leadership in corporate responsibility.

On the consumer front, digital health platforms and telemedicine have redefined how patients access information and therapies. Virtual consultations and e-pharmacy models are growing in prominence, creating new channels for prescription fulfillment and patient education. The ability to track usage patterns through connected adherence devices is also catalyzing data-driven insights into patient behavior, allowing formulators to refine dosage regimens and personalize treatment protocols. This convergence of technology, regulation, and patient engagement is ushering in a new era of suppository development-one that promises heightened efficacy, sustainability, and user-focused design.

Analyzing the Broad Impacts of Newly Implemented United States Tariffs in 2025 on Raw Materials Supply Chains and Industry Competitiveness

In 2025, the introduction of expanded tariffs by the United States on key pharmaceutical raw materials has created significant headwinds for suppository manufacturers who rely on imported excipients. From polyethylene glycol derivatives to glycerinated gelatin bases, the increased duties have escalated input costs and injected volatility into pricing structures. Companies are now challenged to navigate evolving tariff classifications while preserving product quality and competitive positioning.

Response strategies have varied across the industry. Some producers have pursued nearshoring initiatives, forging partnerships with regional chemical suppliers to secure lower-duty supplies and shorten lead times. Others have accelerated efforts to qualify alternative base materials that fall outside the highest tariff brackets, even as they conduct stability and compatibility studies to ensure regulatory compliance. This dual approach of supply-chain diversification and material innovation has become a critical defensive measure in the face of shifting trade policy landscapes.

Long-term implications extend beyond cost management. The tariff environment is driving a reevaluation of global manufacturing footprints, with organizations weighing the benefits of establishing new production lines in duty-free zones against the capital investments required. Concurrently, trade negotiations and industry coalitions are advocating for tariff relief on essential pharmaceutical inputs, arguing that patient access and public health outcomes are at stake. As these dialogues evolve, stakeholders must remain agile, aligning sourcing strategies with policy developments while maintaining the integrity of their suppository formulations.

Uncovering Rich Insights into Product Variation Material Compositions Prescription Dynamics Therapeutic Uses End User Preferences and Distribution Trends

Segmentation by product type reveals distinct performance drivers and clinical considerations across rectal, urethral, and vaginal suppositories. Rectal formulations continue to dominate in analgesic and antiemetic applications due to their rapid absorption and ease of administration, whereas urethral options address specialized urological needs and benefit from advances in polymer compatibility. Vaginal suppositories, meanwhile, are gaining traction for antibacterial, antifungal, and antihemorrhoidal therapies, propelled by patient preferences for discreet, localized treatment.

Material type provides another critical lens for differentiation. Emulsifying bases enhance dissolution and offer targeted release profiles, while fatty bases remain essential for lipophilic drug compounds that require gradual release. Glycerinated gelatin has carved out a niche for moisture-sensitive applications, and water-soluble bases simplify handling and storage. The polyethylene glycol base category, subdivided into PEG 3350 and PEG 4000, exhibits versatility across multiple therapeutic applications due to its tunable melting point and compatibility with both polar and nonpolar actives.

Prescription type delineates usage patterns between over-the-counter remedies and prescription-only therapies. While OTC drugs dominate antihemorrhoidal and laxative segments by offering convenient home care solutions, prescription drugs maintain their stronghold in anti inflammatory, analgesic, and antibacterial domains where close clinical oversight and dosage precision are paramount.

Therapeutic application underscores how analgesic compounds such as acetaminophen and NSAIDs have been formulated into both rectal and urethral dosage forms to mitigate systemic side effects. Antihemorrhoidal treatments, differentiated by steroidal and non-steroidal formulations, require careful balancing of efficacy with mucosal safety. Antiemetic, antibacterial, antifungal, and laxative suppositories each present unique formulation challenges, driving continued research into excipient compatibility and release kinetics.

End user segmentation highlights the diverging demands of home care patients versus hospital and clinic procurement teams. Home care environments prioritize ease of use, pre-filled designs, and clear patient instructions. Hospitals and clinics, on the other hand, emphasize batch consistency, stringent quality controls, and compliance documentation. Distribution channels span offline and online pharmacies, with digital platforms gaining share by offering targeted education, subscription models, and discreet delivery services.

Examining Distinct Regulatory Patient Demand Manufacturing and Distribution Dynamics Across the Americas EMEA and Asia-Pacific Regions for Suppository Solutions

In the Americas, regulatory harmonization across major markets such as the United States, Canada, and Brazil is fostering a robust environment for suppository innovation. Patient demand for non-oral therapies remains high, particularly in chronic pain management and proctology, encouraging local players to invest in advanced base technologies and expand clinical trial pipelines. Simultaneously, trade corridors between North and South America are facilitating raw material exchange, although recent tariff measures are prompting stakeholders to seek new sourcing partnerships within the region.

Europe, the Middle East, and Africa each present unique challenges and opportunities. Stringent safety assessments enforced by the European Medicines Agency drive rigorous excipient evaluation, while emerging markets in the Middle East show growing interest in OTC antihemorrhoidal and antifungal formulations. African health authorities are focused on expanding access to essential medicines, creating potential for donor-supported procurements of basic glycerinated and fatty-base suppositories. Across EMEA, sustainability mandates and environmental packaging regulations are shaping product development roadmaps.

Asia-Pacific stands out as a dynamic theatre where manufacturing scale meets diverse patient needs. Nations such as India and China command significant roles in active pharmaceutical ingredient production, supplying both regional and global markets. At the same time, developed Asia-Pacific economies exhibit strong consumer adoption of premium-base formulations and digital fulfillment channels. Rising healthcare expenditure and expanding cold-chain infrastructure are enabling manufacturers to introduce temperature-sensitive suppository products, further expanding therapeutic reach across the region.

Highlighting Leading Companies Driving Innovation Collaboration and Strategic Partnerships to Advance Suppository Development and Market Impact

Leading pharmaceutical and formulation companies are advancing suppository science through strategic investments in research partnerships and vertical integration efforts. Key innovators are forging alliances with excipient specialists to co-develop next-generation base materials that offer enhanced drug loading and controlled release. These collaborations are underpinned by shared laboratory platforms and joint intellectual property filings, positioning partners to accelerate product pipelines and shorten time to clinical validation.

Several established contract development and manufacturing organizations (CDMOs) have expanded their capabilities to include specialized molding and aseptic packaging for suppository production. By integrating formulation development with end-to-end manufacturing services, these players are streamlining commercialization pathways for both in-house brands and emerging biotechnology firms.

Broader industry consolidation is also underway, with acquisitions aimed at augmenting therapeutic portfolios and geographic footprints. Mid-sized companies are acquiring niche formulators that possess unique emulsifying or polymer expertise, while larger pharmaceutical groups are absorbing regional producers to strengthen supply-chain resilience and regulatory compliance across multiple jurisdictions.

Formulating Strategic Recommendations to Guide Industry Leaders in Optimizing Supply Chains Enhancing Collaboration and Capitalizing on Emerging Suppository Opportunities

Industry leaders should prioritize supply-chain resilience by diversifying sourcing strategies and forging partnerships with regional excipient suppliers, thereby mitigating the effects of evolving tariff and compliance landscapes. Investment in advanced base technology-such as biodegradable polymers and smart excipients that respond to physiological triggers-can unlock new therapeutic possibilities and differentiate formulations in a crowded field.

Collaborative alliances between formulators, clinical research organizations, and patient advocacy groups will be pivotal in accelerating product acceptance and ensuring regulatory alignment. By co-designing clinical studies and real-world evidence programs, stakeholders can demonstrate safety and efficacy more rapidly, fostering trust among prescribers and end users alike.

In parallel, manufacturers should leverage digital health platforms to enhance patient adherence, offering connected applicators, adherence reminders, and telehealth support to streamline treatment protocols. These initiatives not only improve therapeutic outcomes but also generate valuable usage data that can inform future product iterations.

Finally, proactive engagement with policy makers to underscore the public health imperative of reliable suppository access will be essential. Advocacy efforts that highlight global best practices and patient-centric benefits can help secure tariff relief on critical excipients and promote harmonized regulatory frameworks.

Detailing Rigorous Research Approach Combining Primary Expert Engagement Secondary Literature Analysis and Quantitative Data Integration for Reliable Insights

This research report is grounded in a multi-layered methodology designed to ensure robust and actionable insights. Primary research involved in-depth interviews with formulation scientists, regulatory experts, supply-chain managers, and patient advocacy representatives to gather firsthand perspectives on emerging trends and operational challenges. These qualitative inputs were triangulated with secondary research drawn from peer-reviewed journals, industry white papers, regulatory filings, and technical conference proceedings.

A rigorous data integration process was applied to align qualitative findings with quantitative benchmarks, enabling the identification of key value drivers and potential risk factors across the suppository landscape. Excipients and therapeutic application analyses were conducted through cross-validation of academic research, patent filings, and proprietary manufacturer disclosures.

The regional and tariff impact assessments incorporated trade databases, customs records, and policy briefs from governmental agencies to construct a comprehensive view of supply-chain dynamics. Company profiles and competitive positioning analyses were informed by annual reports, investor presentations, and validated press releases, ensuring an accurate portrayal of leading players' strategic priorities.

Ethical considerations and data integrity protocols were maintained throughout, with all sources subjected to peer review and validation checkpoints. This transparent and repeatable approach underpins the credibility of the report's findings and the reliability of its strategic recommendations.

Synthesizing Key Findings and Strategic Implications to Illuminate the Path Forward for Suppository Innovation and Adoption in Healthcare Practices

Throughout this report, the analysis of transformative innovations, tariff-driven supply-chain recalibrations, and nuanced segmentation dynamics has illuminated a rapidly evolving suppository landscape. The convergence of material science breakthroughs, regulatory emphasis on sustainability, and digital health integration underscores an industry poised for significant therapeutic impact.

Regional divergences in regulatory stringency, patient preferences, and manufacturing capacities highlight the importance of tailored strategies. While the Americas focus on harmonized clinical standards, EMEA grapples with stringent safety and environmental mandates, and Asia-Pacific balances scale with increasingly demanding consumer expectations. Leading organizations that master these regional nuances will be best positioned to deliver consistent, high-quality therapies.

Key players are demonstrating that strategic collaborations, whether through CDMO partnerships or excipient co-development, can accelerate innovation and enhance supply-chain resilience. Actionable recommendations emphasize the need for diversified sourcing, advanced base investment, and proactive policy advocacy-critical levers for navigating the complexities of 2025 and beyond.

Looking ahead, the industry's capacity to adapt will hinge on continued investment in patient-centric design, sustainable practices, and data-driven decision-making. Embracing these priorities will ensure that suppository therapies remain a trusted and effective option for clinicians and patients around the world.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

  • 4.1. Introduction
  • 4.2. Market Sizing & Forecasting

5. Market Dynamics

  • 5.1. Increasing adoption of temperature stable lipid based suppositories for tropical markets
  • 5.2. Development of mucoadhesive polymer formulations enhancing controlled drug release profiles
  • 5.3. Rising demand for pediatric and geriatric suppositories with tailored dosing solutions
  • 5.4. Integration of digital health monitoring to optimize patient adherence and outcomes
  • 5.5. Emerging preference for plant derived and natural excipient based suppository formulations
  • 5.6. Advancements in 3d printing enabling personalized suppository dosing and rapid prototyping
  • 5.7. Growing regulatory shifts streamlining approval of novel rectal drug delivery systems
  • 5.8. Expansion of suppository markets in emerging economies driven by rising healthcare access

6. Market Insights

  • 6.1. Porter's Five Forces Analysis
  • 6.2. PESTLE Analysis

7. Cumulative Impact of United States Tariffs 2025

8. Suppositories Market, by Product Type

  • 8.1. Introduction
  • 8.2. Rectal Suppositories
  • 8.3. Urethral Suppositories
  • 8.4. Vaginal Suppositories

9. Suppositories Market, by Material Type

  • 9.1. Introduction
  • 9.2. Emulsifying Bases
  • 9.3. Fatty Bases
  • 9.4. Glycerinated Gelatin Base
  • 9.5. Polyethylene Glycol Base
    • 9.5.1. PEG 3350
    • 9.5.2. PEG 4000
  • 9.6. Water-Soluble Bases

10. Suppositories Market, by Prescription Type

  • 10.1. Introduction
  • 10.2. Over-the-Counter (OTC) Drugs
  • 10.3. Prescription Drugs (Rx)

11. Suppositories Market, by Therapeutic Application

  • 11.1. Introduction
  • 11.2. Analgesic
    • 11.2.1. Acetaminophen Analgesic
    • 11.2.2. NSAID Analgesic
  • 11.3. Anti Inflammatory
  • 11.4. Antibacterial & Antifungal
  • 11.5. Antiemetic
  • 11.6. Antihemorrhoidal
    • 11.6.1. Non Steroidal Formulation
    • 11.6.2. Steroidal Formulation
  • 11.7. Laxative

12. Suppositories Market, by End User

  • 12.1. Introduction
  • 12.2. Home Care
  • 12.3. Hospitals & Clinics

13. Suppositories Market, by Distribution Channel

  • 13.1. Introduction
  • 13.2. Offline Pharmacy
  • 13.3. Online Pharmacy

14. Americas Suppositories Market

  • 14.1. Introduction
  • 14.2. United States
  • 14.3. Canada
  • 14.4. Mexico
  • 14.5. Brazil
  • 14.6. Argentina

15. Europe, Middle East & Africa Suppositories Market

  • 15.1. Introduction
  • 15.2. United Kingdom
  • 15.3. Germany
  • 15.4. France
  • 15.5. Russia
  • 15.6. Italy
  • 15.7. Spain
  • 15.8. United Arab Emirates
  • 15.9. Saudi Arabia
  • 15.10. South Africa
  • 15.11. Denmark
  • 15.12. Netherlands
  • 15.13. Qatar
  • 15.14. Finland
  • 15.15. Sweden
  • 15.16. Nigeria
  • 15.17. Egypt
  • 15.18. Turkey
  • 15.19. Israel
  • 15.20. Norway
  • 15.21. Poland
  • 15.22. Switzerland

16. Asia-Pacific Suppositories Market

  • 16.1. Introduction
  • 16.2. China
  • 16.3. India
  • 16.4. Japan
  • 16.5. Australia
  • 16.6. South Korea
  • 16.7. Indonesia
  • 16.8. Thailand
  • 16.9. Philippines
  • 16.10. Malaysia
  • 16.11. Singapore
  • 16.12. Vietnam
  • 16.13. Taiwan

17. Competitive Landscape

  • 17.1. Market Share Analysis, 2024
  • 17.2. FPNV Positioning Matrix, 2024
  • 17.3. Competitive Analysis
    • 17.3.1. Novartis AG
    • 17.3.2. SANOFI WINTHROP INDUSTRIE
    • 17.3.3. Zydus Group
    • 17.3.4. Church & Dwight Co., Inc.
    • 17.3.5. Bausch Health Companies Inc.
    • 17.3.6. Teva Pharmaceutical Industries Ltd.
    • 17.3.7. Sun Pharmaceutical Industries Ltd.
    • 17.3.8. Aspen Holdings
    • 17.3.9. Haleon Group of Companies
    • 17.3.10. Cipla Limited
    • 17.3.11. Gulf Pharmaceutical Industries
    • 17.3.12. Prestige Consumer Healthcare Inc.
    • 17.3.13. Bliss GVS Pharma Ltd
    • 17.3.14. Corden Pharma
    • 17.3.15. Recipharm AB
    • 17.3.16. Pfizer Inc.
    • 17.3.17. LGM Pharma, LLC
    • 17.3.18. Aenova Group
    • 17.3.19. Bayer AG
    • 17.3.20. Aliyan Pharmaceuticals LLP
    • 17.3.21. Adragos Pharma GmbH

18. ResearchAI

19. ResearchStatistics

20. ResearchContacts

21. ResearchArticles

22. Appendix

LIST OF FIGURES

  • FIGURE 1. SUPPOSITORIES MARKET RESEARCH PROCESS
  • FIGURE 2. GLOBAL SUPPOSITORIES MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 3. GLOBAL SUPPOSITORIES MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 4. GLOBAL SUPPOSITORIES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL SUPPOSITORIES MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2030 (%)
  • FIGURE 6. GLOBAL SUPPOSITORIES MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 7. GLOBAL SUPPOSITORIES MARKET SIZE, BY MATERIAL TYPE, 2024 VS 2030 (%)
  • FIGURE 8. GLOBAL SUPPOSITORIES MARKET SIZE, BY MATERIAL TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 9. GLOBAL SUPPOSITORIES MARKET SIZE, BY PRESCRIPTION TYPE, 2024 VS 2030 (%)
  • FIGURE 10. GLOBAL SUPPOSITORIES MARKET SIZE, BY PRESCRIPTION TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 11. GLOBAL SUPPOSITORIES MARKET SIZE, BY THERAPEUTIC APPLICATION, 2024 VS 2030 (%)
  • FIGURE 12. GLOBAL SUPPOSITORIES MARKET SIZE, BY THERAPEUTIC APPLICATION, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 13. GLOBAL SUPPOSITORIES MARKET SIZE, BY END USER, 2024 VS 2030 (%)
  • FIGURE 14. GLOBAL SUPPOSITORIES MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 15. GLOBAL SUPPOSITORIES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2030 (%)
  • FIGURE 16. GLOBAL SUPPOSITORIES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 17. AMERICAS SUPPOSITORIES MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
  • FIGURE 18. AMERICAS SUPPOSITORIES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 19. UNITED STATES SUPPOSITORIES MARKET SIZE, BY STATE, 2024 VS 2030 (%)
  • FIGURE 20. UNITED STATES SUPPOSITORIES MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 21. EUROPE, MIDDLE EAST & AFRICA SUPPOSITORIES MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
  • FIGURE 22. EUROPE, MIDDLE EAST & AFRICA SUPPOSITORIES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 23. ASIA-PACIFIC SUPPOSITORIES MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
  • FIGURE 24. ASIA-PACIFIC SUPPOSITORIES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 25. SUPPOSITORIES MARKET SHARE, BY KEY PLAYER, 2024
  • FIGURE 26. SUPPOSITORIES MARKET, FPNV POSITIONING MATRIX, 2024
  • FIGURE 27. SUPPOSITORIES MARKET: RESEARCHAI
  • FIGURE 28. SUPPOSITORIES MARKET: RESEARCHSTATISTICS
  • FIGURE 29. SUPPOSITORIES MARKET: RESEARCHCONTACTS
  • FIGURE 30. SUPPOSITORIES MARKET: RESEARCHARTICLES

LIST OF TABLES

  • TABLE 1. SUPPOSITORIES MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
  • TABLE 3. GLOBAL SUPPOSITORIES MARKET SIZE, 2018-2024 (USD MILLION)
  • TABLE 4. GLOBAL SUPPOSITORIES MARKET SIZE, 2025-2030 (USD MILLION)
  • TABLE 5. GLOBAL SUPPOSITORIES MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 6. GLOBAL SUPPOSITORIES MARKET SIZE, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 7. GLOBAL SUPPOSITORIES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 8. GLOBAL SUPPOSITORIES MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
  • TABLE 9. GLOBAL SUPPOSITORIES MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 10. GLOBAL SUPPOSITORIES MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
  • TABLE 11. GLOBAL SUPPOSITORIES MARKET SIZE, BY RECTAL SUPPOSITORIES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 12. GLOBAL SUPPOSITORIES MARKET SIZE, BY RECTAL SUPPOSITORIES, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 13. GLOBAL SUPPOSITORIES MARKET SIZE, BY URETHRAL SUPPOSITORIES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 14. GLOBAL SUPPOSITORIES MARKET SIZE, BY URETHRAL SUPPOSITORIES, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 15. GLOBAL SUPPOSITORIES MARKET SIZE, BY VAGINAL SUPPOSITORIES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 16. GLOBAL SUPPOSITORIES MARKET SIZE, BY VAGINAL SUPPOSITORIES, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 17. GLOBAL SUPPOSITORIES MARKET SIZE, BY MATERIAL TYPE, 2018-2024 (USD MILLION)
  • TABLE 18. GLOBAL SUPPOSITORIES MARKET SIZE, BY MATERIAL TYPE, 2025-2030 (USD MILLION)
  • TABLE 19. GLOBAL SUPPOSITORIES MARKET SIZE, BY EMULSIFYING BASES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 20. GLOBAL SUPPOSITORIES MARKET SIZE, BY EMULSIFYING BASES, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 21. GLOBAL SUPPOSITORIES MARKET SIZE, BY FATTY BASES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 22. GLOBAL SUPPOSITORIES MARKET SIZE, BY FATTY BASES, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 23. GLOBAL SUPPOSITORIES MARKET SIZE, BY GLYCERINATED GELATIN BASE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 24. GLOBAL SUPPOSITORIES MARKET SIZE, BY GLYCERINATED GELATIN BASE, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 25. GLOBAL SUPPOSITORIES MARKET SIZE, BY POLYETHYLENE GLYCOL BASE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 26. GLOBAL SUPPOSITORIES MARKET SIZE, BY POLYETHYLENE GLYCOL BASE, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 27. GLOBAL SUPPOSITORIES MARKET SIZE, BY PEG 3350, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 28. GLOBAL SUPPOSITORIES MARKET SIZE, BY PEG 3350, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 29. GLOBAL SUPPOSITORIES MARKET SIZE, BY PEG 4000, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 30. GLOBAL SUPPOSITORIES MARKET SIZE, BY PEG 4000, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 31. GLOBAL SUPPOSITORIES MARKET SIZE, BY POLYETHYLENE GLYCOL BASE, 2018-2024 (USD MILLION)
  • TABLE 32. GLOBAL SUPPOSITORIES MARKET SIZE, BY POLYETHYLENE GLYCOL BASE, 2025-2030 (USD MILLION)
  • TABLE 33. GLOBAL SUPPOSITORIES MARKET SIZE, BY WATER-SOLUBLE BASES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 34. GLOBAL SUPPOSITORIES MARKET SIZE, BY WATER-SOLUBLE BASES, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 35. GLOBAL SUPPOSITORIES MARKET SIZE, BY PRESCRIPTION TYPE, 2018-2024 (USD MILLION)
  • TABLE 36. GLOBAL SUPPOSITORIES MARKET SIZE, BY PRESCRIPTION TYPE, 2025-2030 (USD MILLION)
  • TABLE 37. GLOBAL SUPPOSITORIES MARKET SIZE, BY OVER-THE-COUNTER (OTC) DRUGS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 38. GLOBAL SUPPOSITORIES MARKET SIZE, BY OVER-THE-COUNTER (OTC) DRUGS, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 39. GLOBAL SUPPOSITORIES MARKET SIZE, BY PRESCRIPTION DRUGS (RX), BY REGION, 2018-2024 (USD MILLION)
  • TABLE 40. GLOBAL SUPPOSITORIES MARKET SIZE, BY PRESCRIPTION DRUGS (RX), BY REGION, 2025-2030 (USD MILLION)
  • TABLE 41. GLOBAL SUPPOSITORIES MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 42. GLOBAL SUPPOSITORIES MARKET SIZE, BY THERAPEUTIC APPLICATION, 2025-2030 (USD MILLION)
  • TABLE 43. GLOBAL SUPPOSITORIES MARKET SIZE, BY ANALGESIC, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 44. GLOBAL SUPPOSITORIES MARKET SIZE, BY ANALGESIC, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 45. GLOBAL SUPPOSITORIES MARKET SIZE, BY ACETAMINOPHEN ANALGESIC, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 46. GLOBAL SUPPOSITORIES MARKET SIZE, BY ACETAMINOPHEN ANALGESIC, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 47. GLOBAL SUPPOSITORIES MARKET SIZE, BY NSAID ANALGESIC, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 48. GLOBAL SUPPOSITORIES MARKET SIZE, BY NSAID ANALGESIC, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 49. GLOBAL SUPPOSITORIES MARKET SIZE, BY ANALGESIC, 2018-2024 (USD MILLION)
  • TABLE 50. GLOBAL SUPPOSITORIES MARKET SIZE, BY ANALGESIC, 2025-2030 (USD MILLION)
  • TABLE 51. GLOBAL SUPPOSITORIES MARKET SIZE, BY ANTI INFLAMMATORY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 52. GLOBAL SUPPOSITORIES MARKET SIZE, BY ANTI INFLAMMATORY, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 53. GLOBAL SUPPOSITORIES MARKET SIZE, BY ANTIBACTERIAL & ANTIFUNGAL, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 54. GLOBAL SUPPOSITORIES MARKET SIZE, BY ANTIBACTERIAL & ANTIFUNGAL, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 55. GLOBAL SUPPOSITORIES MARKET SIZE, BY ANTIEMETIC, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 56. GLOBAL SUPPOSITORIES MARKET SIZE, BY ANTIEMETIC, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 57. GLOBAL SUPPOSITORIES MARKET SIZE, BY ANTIHEMORRHOIDAL, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 58. GLOBAL SUPPOSITORIES MARKET SIZE, BY ANTIHEMORRHOIDAL, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 59. GLOBAL SUPPOSITORIES MARKET SIZE, BY NON STEROIDAL FORMULATION, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 60. GLOBAL SUPPOSITORIES MARKET SIZE, BY NON STEROIDAL FORMULATION, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 61. GLOBAL SUPPOSITORIES MARKET SIZE, BY STEROIDAL FORMULATION, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 62. GLOBAL SUPPOSITORIES MARKET SIZE, BY STEROIDAL FORMULATION, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 63. GLOBAL SUPPOSITORIES MARKET SIZE, BY ANTIHEMORRHOIDAL, 2018-2024 (USD MILLION)
  • TABLE 64. GLOBAL SUPPOSITORIES MARKET SIZE, BY ANTIHEMORRHOIDAL, 2025-2030 (USD MILLION)
  • TABLE 65. GLOBAL SUPPOSITORIES MARKET SIZE, BY LAXATIVE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 66. GLOBAL SUPPOSITORIES MARKET SIZE, BY LAXATIVE, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 67. GLOBAL SUPPOSITORIES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 68. GLOBAL SUPPOSITORIES MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
  • TABLE 69. GLOBAL SUPPOSITORIES MARKET SIZE, BY HOME CARE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 70. GLOBAL SUPPOSITORIES MARKET SIZE, BY HOME CARE, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 71. GLOBAL SUPPOSITORIES MARKET SIZE, BY HOSPITALS & CLINICS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 72. GLOBAL SUPPOSITORIES MARKET SIZE, BY HOSPITALS & CLINICS, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 73. GLOBAL SUPPOSITORIES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 74. GLOBAL SUPPOSITORIES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
  • TABLE 75. GLOBAL SUPPOSITORIES MARKET SIZE, BY OFFLINE PHARMACY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 76. GLOBAL SUPPOSITORIES MARKET SIZE, BY OFFLINE PHARMACY, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 77. GLOBAL SUPPOSITORIES MARKET SIZE, BY ONLINE PHARMACY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 78. GLOBAL SUPPOSITORIES MARKET SIZE, BY ONLINE PHARMACY, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 79. AMERICAS SUPPOSITORIES MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 80. AMERICAS SUPPOSITORIES MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
  • TABLE 81. AMERICAS SUPPOSITORIES MARKET SIZE, BY MATERIAL TYPE, 2018-2024 (USD MILLION)
  • TABLE 82. AMERICAS SUPPOSITORIES MARKET SIZE, BY MATERIAL TYPE, 2025-2030 (USD MILLION)
  • TABLE 83. AMERICAS SUPPOSITORIES MARKET SIZE, BY POLYETHYLENE GLYCOL BASE, 2018-2024 (USD MILLION)
  • TABLE 84. AMERICAS SUPPOSITORIES MARKET SIZE, BY POLYETHYLENE GLYCOL BASE, 2025-2030 (USD MILLION)
  • TABLE 85. AMERICAS SUPPOSITORIES MARKET SIZE, BY PRESCRIPTION TYPE, 2018-2024 (USD MILLION)
  • TABLE 86. AMERICAS SUPPOSITORIES MARKET SIZE, BY PRESCRIPTION TYPE, 2025-2030 (USD MILLION)
  • TABLE 87. AMERICAS SUPPOSITORIES MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 88. AMERICAS SUPPOSITORIES MARKET SIZE, BY THERAPEUTIC APPLICATION, 2025-2030 (USD MILLION)
  • TABLE 89. AMERICAS SUPPOSITORIES MARKET SIZE, BY ANALGESIC, 2018-2024 (USD MILLION)
  • TABLE 90. AMERICAS SUPPOSITORIES MARKET SIZE, BY ANALGESIC, 2025-2030 (USD MILLION)
  • TABLE 91. AMERICAS SUPPOSITORIES MARKET SIZE, BY ANTIHEMORRHOIDAL, 2018-2024 (USD MILLION)
  • TABLE 92. AMERICAS SUPPOSITORIES MARKET SIZE, BY ANTIHEMORRHOIDAL, 2025-2030 (USD MILLION)
  • TABLE 93. AMERICAS SUPPOSITORIES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 94. AMERICAS SUPPOSITORIES MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
  • TABLE 95. AMERICAS SUPPOSITORIES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 96. AMERICAS SUPPOSITORIES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
  • TABLE 97. AMERICAS SUPPOSITORIES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 98. AMERICAS SUPPOSITORIES MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
  • TABLE 99. UNITED STATES SUPPOSITORIES MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 100. UNITED STATES SUPPOSITORIES MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
  • TABLE 101. UNITED STATES SUPPOSITORIES MARKET SIZE, BY MATERIAL TYPE, 2018-2024 (USD MILLION)
  • TABLE 102. UNITED STATES SUPPOSITORIES MARKET SIZE, BY MATERIAL TYPE, 2025-2030 (USD MILLION)
  • TABLE 103. UNITED STATES SUPPOSITORIES MARKET SIZE, BY POLYETHYLENE GLYCOL BASE, 2018-2024 (USD MILLION)
  • TABLE 104. UNITED STATES SUPPOSITORIES MARKET SIZE, BY POLYETHYLENE GLYCOL BASE, 2025-2030 (USD MILLION)
  • TABLE 105. UNITED STATES SUPPOSITORIES MARKET SIZE, BY PRESCRIPTION TYPE, 2018-2024 (USD MILLION)
  • TABLE 106. UNITED STATES SUPPOSITORIES MARKET SIZE, BY PRESCRIPTION TYPE, 2025-2030 (USD MILLION)
  • TABLE 107. UNITED STATES SUPPOSITORIES MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 108. UNITED STATES SUPPOSITORIES MARKET SIZE, BY THERAPEUTIC APPLICATION, 2025-2030 (USD MILLION)
  • TABLE 109. UNITED STATES SUPPOSITORIES MARKET SIZE, BY ANALGESIC, 2018-2024 (USD MILLION)
  • TABLE 110. UNITED STATES SUPPOSITORIES MARKET SIZE, BY ANALGESIC, 2025-2030 (USD MILLION)
  • TABLE 111. UNITED STATES SUPPOSITORIES MARKET SIZE, BY ANTIHEMORRHOIDAL, 2018-2024 (USD MILLION)
  • TABLE 112. UNITED STATES SUPPOSITORIES MARKET SIZE, BY ANTIHEMORRHOIDAL, 2025-2030 (USD MILLION)
  • TABLE 113. UNITED STATES SUPPOSITORIES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 114. UNITED STATES SUPPOSITORIES MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
  • TABLE 115. UNITED STATES SUPPOSITORIES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 116. UNITED STATES SUPPOSITORIES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
  • TABLE 117. UNITED STATES SUPPOSITORIES MARKET SIZE, BY STATE, 2018-2024 (USD MILLION)
  • TABLE 118. UNITED STATES SUPPOSITORIES MARKET SIZE, BY STATE, 2025-2030 (USD MILLION)
  • TABLE 119. CANADA SUPPOSITORIES MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 120. CANADA SUPPOSITORIES MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
  • TABLE 121. CANADA SUPPOSITORIES MARKET SIZE, BY MATERIAL TYPE, 2018-2024 (USD MILLION)
  • TABLE 122. CANADA SUPPOSITORIES MARKET SIZE, BY MATERIAL TYPE, 2025-2030 (USD MILLION)
  • TABLE 123. CANADA SUPPOSITORIES MARKET SIZE, BY POLYETHYLENE GLYCOL BASE, 2018-2024 (USD MILLION)
  • TABLE 124. CANADA SUPPOSITORIES MARKET SIZE, BY POLYETHYLENE GLYCOL BASE, 2025-2030 (USD MILLION)
  • TABLE 125. CANADA SUPPOSITORIES MARKET SIZE, BY PRESCRIPTION TYPE, 2018-2024 (USD MILLION)
  • TABLE 126. CANADA SUPPOSITORIES MARKET SIZE, BY PRESCRIPTION TYPE, 2025-2030 (USD MILLION)
  • TABLE 127. CANADA SUPPOSITORIES MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 128. CANADA SUPPOSITORIES MARKET SIZE, BY THERAPEUTIC APPLICATION, 2025-2030 (USD MILLION)
  • TABLE 129. CANADA SUPPOSITORIES MARKET SIZE, BY ANALGESIC, 2018-2024 (USD MILLION)
  • TABLE 130. CANADA SUPPOSITORIES MARKET SIZE, BY ANALGESIC, 2025-2030 (USD MILLION)
  • TABLE 131. CANADA SUPPOSITORIES MARKET SIZE, BY ANTIHEMORRHOIDAL, 2018-2024 (USD MILLION)
  • TABLE 132. CANADA SUPPOSITORIES MARKET SIZE, BY ANTIHEMORRHOIDAL, 2025-2030 (USD MILLION)
  • TABLE 133. CANADA SUPPOSITORIES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 134. CANADA SUPPOSITORIES MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
  • TABLE 135. CANADA SUPPOSITORIES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 136. CANADA SUPPOSITORIES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
  • TABLE 137. MEXICO SUPPOSITORIES MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 138. MEXICO SUPPOSITORIES MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
  • TABLE 139. MEXICO SUPPOSITORIES MARKET SIZE, BY MATERIAL TYPE, 2018-2024 (USD MILLION)
  • TABLE 140. MEXICO SUPPOSITORIES MARKET SIZE, BY MATERIAL TYPE, 2025-2030 (USD MILLION)
  • TABLE 141. MEXICO SUPPOSITORIES MARKET SIZE, BY POLYETHYLENE GLYCOL BASE, 2018-2024 (USD MILLION)
  • TABLE 142. MEXICO SUPPOSITORIES MARKET SIZE, BY POLYETHYLENE GLYCOL BASE, 2025-2030 (USD MILLION)
  • TABLE 143. MEXICO SUPPOSITORIES MARKET SIZE, BY PRESCRIPTION TYPE, 2018-2024 (USD MILLION)
  • TABLE 144. MEXICO SUPPOSITORIES MARKET SIZE, BY PRESCRIPTION TYPE, 2025-2030 (USD MILLION)
  • TABLE 145. MEXICO SUPPOSITORIES MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 146. MEXICO SUPPOSITORIES MARKET SIZE, BY THERAPEUTIC APPLICATION, 2025-2030 (USD MILLION)
  • TABLE 147. MEXICO SUPPOSITORIES MARKET SIZE, BY ANALGESIC, 2018-2024 (USD MILLION)
  • TABLE 148. MEXICO SUPPOSITORIES MARKET SIZE, BY ANALGESIC, 2025-2030 (USD MILLION)
  • TABLE 149. MEXICO SUPPOSITORIES MARKET SIZE, BY ANTIHEMORRHOIDAL, 2018-2024 (USD MILLION)
  • TABLE 150. MEXICO SUPPOSITORIES MARKET SIZE, BY ANTIHEMORRHOIDAL, 2025-2030 (USD MILLION)
  • TABLE 151. MEXICO SUPPOSITORIES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 152. MEXICO SUPPOSITORIES MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
  • TABLE 153. MEXICO SUPPOSITORIES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 154. MEXICO SUPPOSITORIES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
  • TABLE 155. BRAZIL SUPPOSITORIES MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 156. BRAZIL SUPPOSITORIES MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
  • TABLE 157. BRAZIL SUPPOSITORIES MARKET SIZE, BY MATERIAL TYPE, 2018-2024 (USD MILLION)
  • TABLE 158. BRAZIL SUPPOSITORIES MARKET SIZE, BY MATERIAL TYPE, 2025-2030 (USD MILLION)
  • TABLE 159. BRAZIL SUPPOSITORIES MARKET SIZE, BY POLYETHYLENE GLYCOL BASE, 2018-2024 (USD MILLION)
  • TABLE 160. BRAZIL SUPPOSITORIES MARKET SIZE, BY POLYETHYLENE GLYCOL BASE, 2025-2030 (USD MILLION)
  • TABLE 161. BRAZIL SUPPOSITORIES MARKET SIZE, BY PRESCRIPTION TYPE, 2018-2024 (USD MILLION)
  • TABLE 162. BRAZIL SUPPOSITORIES MARKET SIZE, BY PRESCRIPTION TYPE, 2025-2030 (USD MILLION)
  • TABLE 163. BRAZIL SUPPOSITORIES MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 164. BRAZIL SUPPOSITORIES MARKET SIZE, BY THERAPEUTIC APPLICATION, 2025-2030 (USD MILLION)
  • TABLE 165. BRAZIL SUPPOSITORIES MARKET SIZE, BY ANALGESIC, 2018-2024 (USD MILLION)
  • TABLE 166. BRAZIL SUPPOSITORIES MARKET SIZE, BY ANALGESIC, 2025-2030 (USD MILLION)
  • TABLE 167. BRAZIL SUPPOSITORIES MARKET SIZE, BY ANTIHEMORRHOIDAL, 2018-2024 (USD MILLION)
  • TABLE 168. BRAZIL SUPPOSITORIES MARKET SIZE, BY ANTIHEMORRHOIDAL, 2025-2030 (USD MILLION)
  • TABLE 169. BRAZIL SUPPOSITORIES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 170. BRAZIL SUPPOSITORIES MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
  • TABLE 171. BRAZIL SUPPOSITORIES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 172. BRAZIL SUPPOSITORIES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
  • TABLE 173. ARGENTINA SUPPOSITORIES MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 174. ARGENTINA SUPPOSITORIES MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
  • TABLE 175. ARGENTINA SUPPOSITORIES MARKET SIZE, BY MATERIAL TYPE, 2018-2024 (USD MILLION)
  • TABLE 176. ARGENTINA SUPPOSITORIES MARKET SIZE, BY MATERIAL TYPE, 2025-2030 (USD MILLION)
  • TABLE 177. ARGENTINA SUPPOSITORIES MARKET SIZE, BY POLYETHYLENE GLYCOL BASE, 2018-2024 (USD MILLION)
  • TABLE 178. ARGENTINA SUPPOSITORIES MARKET SIZE, BY POLYETHYLENE GLYCOL BASE, 2025-2030 (USD MILLION)
  • TABLE 179. ARGENTINA SUPPOSITORIES MARKET SIZE, BY PRESCRIPTION TYPE, 2018-2024 (USD MILLION)
  • TABLE 180. ARGENTINA SUPPOSITORIES MARKET SIZE, BY PRESCRIPTION TYPE, 2025-2030 (USD MILLION)
  • TABLE 181. ARGENTINA SUPPOSITORIES MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 182. ARGENTINA SUPPOSITORIES MARKET SIZE, BY THERAPEUTIC APPLICATION, 2025-2030 (USD MILLION)
  • TABLE 183. ARGENTINA SUPPOSITORIES MARKET SIZE, BY ANALGESIC, 2018-2024 (USD MILLION)
  • TABLE 184. ARGENTINA SUPPOSITORIES MARKET SIZE, BY ANALGESIC, 2025-2030 (USD MILLION)
  • TABLE 185. ARGENTINA SUPPOSITORIES MARKET SIZE, BY ANTIHEMORRHOIDAL, 2018-2024 (USD MILLION)
  • TABLE 186. ARGENTINA SUPPOSITORIES MARKET SIZE, BY ANTIHEMORRHOIDAL, 2025-2030 (USD MILLION)
  • TABLE 187. ARGENTINA SUPPOSITORIES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 188. ARGENTINA SUPPOSITORIES MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
  • TABLE 189. ARGENTINA SUPPOSITORIES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 190. ARGENTINA SUPPOSITORIES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
  • TABLE 191. EUROPE, MIDDLE EAST & AFRICA SUPPOSITORIES MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 192. EUROPE, MIDDLE EAST & AFRICA SUPPOSITORIES MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
  • TABLE 193. EUROPE, MIDDLE EAST & AFRICA SUPPOSITORIES MARKET SIZE, BY MATERIAL TYPE, 2018-2024 (USD MILLION)
  • TABLE 194. EUROPE, MIDDLE EAST & AFRICA SUPPOSITORIES MARKET SIZE, BY MATERIAL TYPE, 2025-2030 (USD MILLION)
  • TABLE 195. EUROPE, MIDDLE EAST & AFRICA SUPPOSITORIES MARKET SIZE, BY POLYETHYLENE GLYCOL BASE, 2018-2024 (USD MILLION)
  • TABLE 196. EUROPE, MIDDLE EAST & AFRICA SUPPOSITORIES MARKET SIZE, BY POLYETHYLENE GLYCOL BASE, 2025-2030 (USD MILLION)
  • TABLE 197. EUROPE, MIDDLE EAST & AFRICA SUPPOSITORIES MARKET SIZE, BY PRESCRIPTION TYPE, 2018-2024 (USD MILLION)
  • TABLE 198. EUROPE, MIDDLE EAST & AFRICA SUPPOSITORIES MARKET SIZE, BY PRESCRIPTION TYPE, 2025-2030 (USD MILLION)
  • TABLE 199. EUROPE, MIDDLE EAST & AFRICA SUPPOSITORIES MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 200. EUROPE, MIDDLE EAST & AFRICA SUPPOSITORIES MARKET SIZE, BY THERAPEUTIC APPLICATION, 2025-2030 (USD MILLION)
  • TABLE 201. EUROPE, MIDDLE EAST & AFRICA SUPPOSITORIES MARKET SIZE, BY ANALGESIC, 2018-2024 (USD MILLION)
  • TABLE 202. EUROPE, MIDDLE EAST & AFRICA SUPPOSITORIES MARKET SIZE, BY ANALGESIC, 2025-2030 (USD MILLION)
  • TABLE 203. EUROPE, MIDDLE EAST & AFRICA SUPPOSITORIES MARKET SIZE, BY ANTIHEMORRHOIDAL, 2018-2024 (USD MILLION)
  • TABLE 204. EUROPE, MIDDLE EAST & AFRICA SUPPOSITORIES MARKET SIZE, BY ANTIHEMORRHOIDAL, 2025-2030 (USD MILLION)
  • TABLE 205. EUROPE, MIDDLE EAST & AFRICA SUPPOSITORIES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 206. EUROPE, MIDDLE EAST & AFRICA SUPPOSITORIES MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
  • TABLE 207. EUROPE, MIDDLE EAST & AFRICA SUPPOSITORIES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 208. EUROPE, MIDDLE EAST & AFRICA SUPPOSITORIES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
  • TABLE 209. EUROPE, MIDDLE EAST & AFRICA SUPPOSITORIES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 210. EUROPE, MIDDLE EAST & AFRICA SUPPOSITORIES MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
  • TABLE 211. UNITED KINGDOM SUPPOSITORIES MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 212. UNITED KINGDOM SUPPOSITORIES MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
  • TABLE 213. UNITED KINGDOM SUPPOSITORIES MARKET SIZE, BY MATERIAL TYPE, 2018-2024 (USD MILLION)
  • TABLE 214. UNITED KINGDOM SUPPOSITORIES MARKET SIZE, BY MATERIAL TYPE, 2025-2030 (USD MILLION)
  • TABLE 215. UNITED KINGDOM SUPPOSITORIES MARKET SIZE, BY POLYETHYLENE GLYCOL BASE, 2018-2024 (USD MILLION)
  • TABLE 216. UNITED KINGDOM SUPPOSITORIES MARKET SIZE, BY POLYETHYLENE GLYCOL BASE, 2025-2030 (USD MILLION)
  • TABLE 217. UNITED KINGDOM SUPPOSITORIES MARKET SIZE, BY PRESCRIPTION TYPE, 2018-2024 (USD MILLION)
  • TABLE 218. UNITED KINGDOM SUPPOSITORIES MARKET SIZE, BY PRESCRIPTION TYPE, 2025-2030 (USD MILLION)
  • TABLE 219. UNITED KINGDOM SUPPOSITORIES MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 220. UNITED KINGDOM SUPPOSITORIES MARKET SIZE, BY THERAPEUTIC APPLICATION, 2025-2030 (USD MILLION)
  • TABLE 221. UNITED KINGDOM SUPPOSITORIES MARKET SIZE, BY ANALGESIC, 2018-2024 (USD MILLION)
  • TABLE 222. UNITED KINGDOM SUPPOSITORIES MARKET SIZE, BY ANALGESIC, 2025-2030 (USD MILLION)
  • TABLE 223. UNITED KINGDOM SUPPOSITORIES MARKET SIZE, BY ANTIHEMORRHOIDAL, 2018-2024 (USD MILLION)
  • TABLE 224. UNITED KINGDOM SUPPOSITORIES MARKET SIZE, BY ANTIHEMORRHOIDAL, 2025-2030 (USD MILLION)
  • TABLE 225. UNITED KINGDOM SUPPOSITORIES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 226. UNITED KINGDOM SUPPOSITORIES MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
  • TABLE 227. UNITED KINGDOM SUPPOSITORIES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 228. UNITED KINGDOM SUPPOSITORIES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
  • TABLE 229. GERMANY SUPPOSITORIES MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 230. GERMANY SUPPOSITORIES MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
  • TABLE 231. GERMANY SUPPOSITORIES MARKET SIZE, BY MATERIAL TYPE, 2018-2024 (USD MILLION)
  • TABLE 232. GERMANY SUPPOSITORIES MARKET SIZE, BY MATERIAL TYPE, 2025-2030 (USD MILLION)
  • TABLE 233. GERMANY SUPPOSITORIES MARKET SIZE, BY POLYETHYLENE GLYCOL BASE, 2018-2024 (USD MILLION)
  • TABLE 234. GERMANY SUPPOSITORIES MARKET SIZE, BY POLYETHYLENE GLYCOL BASE, 2025-2030 (USD MILLION)
  • TABLE 235. GERMANY SUPPOSITORIES MARKET SIZE, BY PRESCRIPTION TYPE, 2018-2024 (USD MILLION)
  • TABLE 236. GERMANY SUPPOSITORIES MARKET SIZE, BY PRESCRIPTION TYPE, 2025-2030 (USD MILLION)
  • TABLE 237. GERMANY SUPPOSITORIES MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 238. GERMANY SUPPOSITORIES MARKET SIZE, BY THERAPEUTIC APPLICATION, 2025-2030 (USD MILLION)
  • TABLE 239. GERMANY SUPPOSITORIES MARKET SIZE, BY ANALGESIC, 2018-2024 (USD MILLION)
  • TABLE 240. GERMANY SUPPOSITORIES MARKET SIZE, BY ANALGESIC, 2025-2030 (USD MILLION)
  • TABLE 241. GERMANY SUPPOSITORIES MARKET SIZE, BY ANTIHEMORRHOIDAL, 2018-2024 (USD MILLION)
  • TABLE 242. GERMANY SUPPOSITORIES MARKET SIZE, BY ANTIHEMORRHOIDAL, 2025-2030 (USD MILLION)
  • TABLE 243. GERMANY SUPPOSITORIES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 244. GERMANY SUPPOSITORIES MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
  • TABLE 245. GERMANY SUPPOSITORIES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 246. GERMANY SUPPOSITORIES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
  • TABLE 247. FRANCE SUPPOSITORIES MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 248. FRANCE SUPPOSITORIES MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
  • TABLE 249. FRANCE SUPPOSITORIES MARKET SIZE, BY MATERIAL TYPE, 2018-2024 (USD MILLION)
  • TABLE 250. FRANCE SUPPOSITORIES MARKET SIZE, BY MATERIAL TYPE, 2025-2030 (USD MILLION)
  • TABLE 251. FRANCE SUPPOSITORIES MARKET SIZE, BY POLYETHYLENE GLYCOL BASE, 2018-2024 (USD MILLION)
  • TABLE 252. FRANCE SUPPOSITORIES MARKET SIZE, BY POLYETHYLENE GLYCOL BASE, 2025-2030 (USD MILLION)
  • TABLE 253. FRANCE SUPPOSITORIES MARKET SIZE, BY PRESCRIPTION TYPE, 2018-2024 (USD MILLION)
  • TABLE 254. FRANCE SUPPOSITORIES MARKET SIZE, BY PRESCRIPTION TYPE, 2025-2030 (USD MILLION)
  • TABLE 255. FRANCE SUPPOSITORIES MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 256. FRANCE SUPPOSITORIES MARKET SIZE, BY THERAPEUTIC APPLICATION, 2025-2030 (USD MILLION)
  • TABLE 257. FRANCE SUPPOSITORIES MARKET SIZE, BY ANALGESIC, 2018-2024 (USD MILLION)
  • TABLE 258. FRANCE SUPPOSITORIES MARKET SIZE, BY ANALGESIC, 2025-2030 (USD MILLION)
  • TABLE 259. FRANCE SUPPOSITORIES MARKET SIZE, BY ANTIHEMORRHOIDAL, 2018-2024 (USD MILLION)
  • TABLE 260. FRANCE SUPPOSITORIES MARKET SIZE, BY ANTIHEMORRHOIDAL, 2025-2030 (USD MILLION)
  • TABLE 261. FRANCE SUPPOSITORIES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 262. FRANCE SUPPOSITORIES MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
  • TABLE 263. FRANCE SUPPOSITORIES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 264. FRANCE SUPPOSITORIES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
  • TABLE 265. RUSSIA SUPPOSITORIES MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 266. RUSSIA SUPPOSITORIES MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
  • TABLE 267. RUSSIA SUPPOSITORIES MARKET SIZE, BY MATERIAL TYPE, 2018-2024 (USD MILLION)
  • TABLE 268. RUSSIA SUPPOSITORIES MARKET SIZE, BY MATERIAL TYPE, 2025-2030 (USD MILLION)
  • TABLE 269. RUSSIA SUPPOSITORIES MARKET SIZE, BY POLYETHYLENE GLYCOL BASE, 2018-2024 (USD MILLION)
  • TABLE 270. RUSSIA SUPPOSITORIES MARKET SIZE, BY POLYETHYLENE GLYCOL BASE, 2025-2030 (USD MILLION)
  • TABLE 271. RUSSIA SUPPOSITORIES MARKET SIZE, BY PRESCRIPTION TYPE, 2018-2024 (USD MILLION)
  • TABLE 272. RUSSIA SUPPOSITORIES MARKET SIZE, BY PRESCRIPTION TYPE, 2025-2030 (USD MILLION)
  • TABLE 273. RUSSIA SUPPOSITORIES MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 274. RUSSIA SUPPOSITORIES MARKET SIZE, BY THERAPEUTIC APPLICATION, 2025-2030 (USD MILLION)
  • TABLE 275. RUSSIA SUPPOSITORIES MARKET SIZE, BY ANALGESIC, 2018-2024 (USD MILLION)
  • TABLE 276. RUSSIA SUPPOSITORIES MARKET SIZE, BY ANALGESIC, 2025-2030 (USD MILLION)
  • TABLE 277. RUSSIA SUPPOSITORIES MARKET SIZE, BY ANTIHEMORRHOIDAL, 2018-2024 (USD MILLION)
  • TABLE 278. RUSSIA SUPPOSITORIES MARKET SIZE, BY ANTIHEMORRHOIDAL, 2025-2030 (USD MILLION)
  • TABLE 279. RUSSIA SUPPOSITORIES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 280. RUSSIA SUPPOSITORIES MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
  • TABLE 281. RUSSIA SUPPOSITORIES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 282. RUSSIA SUPPOSITORIES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
  • TABLE 283. ITALY SUPPOSITORIES MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 284. ITALY SUPPOSITORIES MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
  • TABLE 285. ITALY SUPPOSITORIES MARKET SIZE, BY MATERIAL TYPE, 2018-2024 (USD MILLION)
  • TABLE 286. ITALY SUPPOSITORIES MARKET SIZE, BY MATERIAL TYPE, 2025-2030 (USD MILLION)
  • TABLE 287. ITALY SUPPOSITORIES MARKET SIZE, BY POLYETHYLENE GLYCOL BASE, 2018-2024 (USD MILLION)
  • TABLE 288. ITALY SUPPOSITORIES MARKET SIZE, BY POLYETHYLENE GLYCOL BASE, 2025-2030 (USD MILLION)
  • TABLE 289. ITALY SUPPOSITORIES MARKET SIZE, BY PRESCRIPTION TYPE, 2018-2024 (USD MILLION)
  • TABLE 290. ITALY SUPPOSITORIES MARKET SIZE, BY PRESCRIPTION TYPE, 2025-2030 (USD MILLION)
  • TABLE 291. ITALY SUPPOSITORIES MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 292. ITALY SUPPOSITORIES MARKET SIZE, BY THERAPEUTIC APPLICATION, 2025-2030 (USD MILLION)
  • TABLE 293. ITALY SUPPOSITORIES MARKET SIZE, BY ANALGESIC, 2018-2024 (USD MILLION)
  • TABLE 294. ITALY SUPPOSITORIES MARKET SIZE, BY ANALGESIC, 2025-2030 (USD MILLION)
  • TABLE 295. ITALY SUPPOSITORIES MARKET SIZE, BY ANTIHEMORRHOIDAL, 2018-2024 (USD MILLION)
  • TABLE 296. ITALY SUPPOSITORIES MARKET SIZE, BY ANTIHEMORRHOIDAL, 2025-2030 (USD MILLION)
  • TABLE 297. ITALY SUPPOSITORIES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 298. ITALY SUPPOSITORIES MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
  • TABLE 299. ITALY SUPPOSITORIES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 300. ITALY SUPPOSITORIES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
  • TABLE 301. SPAIN SUPPOSITORIES MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 302. SPAIN SUPPOSITORIES MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
  • TABLE 303. SPAIN SUPPOSITORIES MARKET SIZE, BY MATERIAL TYPE, 2018-2024 (USD MILLION)
  • TABLE 304. SPAIN SUPPOSITORIES MARKET SIZE, BY MATERIAL TYPE, 2025-2030 (USD MILLION)
  • TABLE 305. SPAIN SUPPOSITORIES MARKET SIZE, BY POLYETHYLENE GLYCOL BASE, 2018-2024 (USD MILLION)
  • TABLE 306. SPAIN SUPPOSITORIES MARKET SIZE, BY POLYETHYLENE GLYCOL BASE, 2025-2030 (USD MILLION)
  • TABLE 307. SPAIN SUPPOSITORIES MARKET SIZE, BY PRESCRIPTION TYPE, 2018-2024 (USD MILLION)
  • TABLE 308. SPAIN SUPPOSITORIES MARKET SIZE, BY PRESCRIPTION TYPE, 2025-2030 (USD MILLION)
  • TABLE 309. SPAIN SUPPOSITORIES MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 310. SPAIN SUPPOSITORIES MARKET SIZE, BY THERAPEUTIC APPLICATION, 2025-2030 (USD MILLION)
  • TABLE 311. SPAIN SUPPOSITORIES MARKET SIZE, BY ANALGESIC, 2018-2024 (USD MILLION)
  • TABLE 312. SPAIN SUPPOSITORIES MARKET SIZE, BY ANALGESIC, 2025-2030 (USD MILLION)
  • TABLE 313. SPAIN SUPPOSITORIES MARKET SIZE, BY ANTIHEMORRHOIDAL, 2018-2024 (USD MILLION)
  • TABLE 314. SPAIN SUPPOSITORIES MARKET SIZE, BY ANTIHEMORRHOIDAL, 2025-2030 (USD MILLION)
  • TABLE 315. SPAIN SUPPOSITORIES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 316. SPAIN SUPPOSITORIES MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
  • TABLE 317. SPAIN SUPPOSITORIES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 318. SPAIN SUPPOSITORIES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
  • TABLE 319. UNITED ARAB EMIRATES SUPPOSITORIES MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 320. UNITED ARAB EMIRATES SUPPOSITORIES MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
  • TABLE 321. UNITED ARAB EMIRATES SUPPOSITORIES MARKET SIZE, BY MATERIAL TYPE, 2018-2024 (USD MILLION)
  • TABLE 322. UNITED ARAB EMIRATES SUPPOSITORIES MARKET SIZE, BY MATERIAL TYPE, 2025-2030 (USD MILLION)
  • TABLE 323. UNITED ARAB EMIRATES SUPPOSITORIES MARKET SIZE, BY POLYETHYLENE GLYCOL BASE, 2018-2024 (USD MILLION)
  • TABLE 324. UNITED ARAB EMIRATES SUPPOSITORIES MARKET SIZE, BY POLYETHYLENE GLYCOL BASE, 2025-2030 (USD MILLION)
  • TABLE 325. UNITED ARAB EMIRATES SUPPOSITORIES MARKET SIZE, BY PRESCRIPTION TYPE, 2018-2024 (USD MILLION)
  • TABLE 326. UNITED ARAB EMIRATES SUPPOSITORIES MARKET SIZE, BY PRESCRIPTION TYPE, 2025-2030 (USD MILLION)
  • TABLE 327. UNITED ARAB EMIRATES SUPPOSITORIES MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 328. UNITED ARAB EMIRATES SUPPOSITORIES MARKET SIZE, BY THERAPEUTIC APPLICATION, 2025-2030 (USD MILLION)
  • TABLE 329. UNITED ARAB EMIRATES SUPPOSITORIES MARKET SIZE, BY ANALGESIC, 2018-2024 (USD MILLION)
  • TABLE 330. UNITED ARAB EMIRATES SUPPOSITORIES MARKET SIZE, BY ANALGESIC, 2025-2030 (USD MILLION)
  • TABLE 331. UNITED ARAB EMIRATES SUPPOSITORIES MARKET SIZE, BY ANTIHEMORRHOIDAL, 2018-2024 (USD MILLION)
  • TABLE 332. UNITED ARAB EMIRATES SUPPOSITORIES MARKET SIZE, BY ANTIHEMORRHOIDAL, 2025-2030 (USD MILLION)
  • TABLE 333. UNITED ARAB EMIRATES SUPPOSITORIES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 334. UNITED ARAB EMIRATES SUPPOSITORIES MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
  • TABLE 335. UNITED ARAB EMIRATES SUPPOSITORIES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 336. UNITED ARAB EMIRATES SUPPOSITORIES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
  • TABLE 337. SAUDI ARABIA SUPPOSITORIES MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 338. SAUDI ARABIA SUPPOSITORIES MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
  • TABLE 339. SAUDI ARABIA SUPPOSITORIES MARKET SIZE, BY MATERIAL TYPE, 2018-2024 (USD MILLION)
  • TABLE 340. SAUDI ARABIA SUPPOSITORIES MARKET SIZE, BY MATERIAL TYPE, 2025-2030 (USD MILLION)
  • TABLE 341. SAUDI ARABIA SUPPOSITORIES MARKET SIZE, BY POLYETHYLENE GLYCOL BASE, 2018-2024 (USD MILLION)
  • TABLE 342. SAUDI ARABIA SUPPOSITORIES MARKET SIZE, BY POLYETHYLENE GLYCOL BASE, 2025-2030 (USD MILLION)
  • TABLE 343. SAUDI ARABIA SUPPOSITORIES MARKET SIZE, BY PRESCRIPTION TYPE, 2018-2024 (USD MILLION)
  • TABLE 344. SAUDI ARABIA SUPPOSITORIES MARKET SIZE, BY PRESCRIPTION TYPE, 2025-2030 (USD MILLION)
  • TABLE 345. SAUDI ARABIA SUPPOSITORIES MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 346. SAUDI ARABIA SUPPOSITORIES MARKET SIZE, BY THERAPEUTIC APPLICATION, 2025-2030 (USD MILLION)
  • TABLE 347. SAUDI ARABIA SUPPOSITORIES MARKET SIZE, BY ANALGESIC, 2018-2024 (USD MILLION)
  • TABLE 348. SAUDI ARABIA SUPPOSITORIES MARKET SIZE, BY ANALGESIC, 2025-2030 (USD MILLION)
  • TABLE 349. SAUDI ARABIA SUPPOSITORIES MA